compound 9b

Compound 9b is a synthetic small molecule belonging to a library of 1,2,3-triazole-incorporated 1,3,4-oxadiazole-triazine derivatives. It was developed and evaluated for its potential antineoplastic properties against several human cancer cell lines. The compound's structure combines triazole and oxadiazole moieties, which are significant pharmacophores in medicinal chemistry known for their diverse biological activities. In preclinical in vitro studies using the MTT assay, compound 9b and its analogs demonstrated significant cytotoxic activity against prostate cancer (PC3 and DU-145), lung cancer (A549), and breast cancer (MCF-7) cell lines, with IC50 values in the micromolar range. The design of this series involved molecular docking studies to assess binding interactions, positioning these derivatives as candidates for further development in targeted cancer therapy.